Contribution of factor VII genotype to activated FVII levels: Differences in genotype frequencies between northern and southern European populations

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2548-2553

  Bernardi, F ^a   Arcieri, P ^b   Bertina, R M ^c   Chiarotti, F ^d   Corral, J ^e   Pinotti, M ^a   Prydz, H ^f   Samama, M ^g   Sandset, P M ^f   Strom, R ^b   Vicente Garcia, V ^e   Mariani, G ^h  

^a UNIVERSITY OF FERRARA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f UNIVERSITY OF OSLO   (Norway)

^g Laboratoire Central d'Hematologie   (France)

^h UNIVERSITY OF PALERMO   (Italy)

Author keywords

Factor VII genotype; Factor VIIa; Multicenter study

Indexed keywords

BLOOD CLOTTING FACTOR 7; DNA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FRANCE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; ITALY; MALE; NETHERLANDS; NORMAL HUMAN; NORWAY; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SPAIN;

EID: 17344368674     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2548     Document Type: Article

References (16)

1. Meade TW, Mellows S, Brozovic M, et al. Hemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
2. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation. 1994;90:61-68.
3. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosemberg RD. Increased activation of the hemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost. 1996;75: 767-771.
4. Ruddock V, Meade Tw. Factor VII activity and ischemic heart disease: fatal and non-fatal events. Q J Med. 1994;87:403-406.
5. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
6. Folsom AR, Wu KK, Shahar E, Davis CE. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb. 1993;13: 1829-1836.
7. Mennen LI, Scheuten EG, Grobbee DE, Kluft C. Coagulation factor VII, dietary fat and blood lipids: a review. Thromb Haemost. 1996;76:492-499.
8. Seligsohn U, Kasper CK, Osterud B, Rapaport SI, Activated factor VII: presence in factor IX concentrated and persistence in the circulation after infusion. Blood. 1978;53:828.
9. Osterud B. Activation pathway of the coagulation system in normal haemostasis. Scand J Haematol. 1984;32:337.
10. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry. 1991;30:10819.
11. Green F, Kelleher C, Wilkes H, Temple A, Meade TW, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb. 1991;11:540-546.
12. Bernardi F, Marchetti G, Pinotti M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol. 1996;16: 72-76.
13. Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost. 1996;75:567-572.
14. Silveira A, Green F, Karpe F, Blomback M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost. 1994;72:734-739.
15. Kario K, Narita N, Matsuo T, et al. Genetic determinant of plasma FVII activity in the Japanese. Thromb Haemost. 1995;73:617-622.
16. Neuenschwander PF, Morrissey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII, but not cofactor function: analysis of a mutant with a selective deficiency in activity. J Biol Chem. 1992;267:14477.